Literature DB >> 32638263

The Influence of Bifidobacterium bifidum and Bacteroides fragilis on Enteric Glial Cell-Derived Neurotrophic Factors and Inflammasome.

Peng-Chun Yang1, Xi-Jun Li1,2, Yan-Hua Yang1, Wei Qian3, Shi-Yu Li1, Cai-Hua Yan1, Jing Wang1, Qin Wang1, Xiao-Hua Hou3, Chi-Bing Dai4.   

Abstract

Enteric glial cells (EGCs) and enteric glial-derived neurotrophic factor (GDNF) are directly involved in intestinal inflammation. In this study, we sought to examine the possible mechanisms for how Bifidobacterium bifidum (B.b.) and Bacteroides fragilis (B.f.) influence EGC regulation. In this study, lipopolysaccharide (LPS) and interferon-γ (IFN-γ) were used as exogenous stimuli of EGCs to establish an intestinal inflammation model. After stimulation with LPS and IFN-γ, B.b. and B.f. supernatants were used to activate EGCs and to examine EGC immune mechanisms. For this purpose, qRT-PCR, western blotting, and laser scanning confocal microscopy (LSCM) were used to detect the expression of NLRP3, NLRP6, NGF, NT-3, IL-18, IL-1β, and caspase-1. We found that EGCs, after stimulation with LPS and IFN-γ, could express NLRP3, NLRP6, NT-3, NGF, IL-18, IL-1β, and caspase-1 through LSCM. In intestinal inflammation, B.b. and B.f. could trigger an increase in NGF and NT-3 expression in EGCs in order to protect the intestine. Furthermore, B.b. and B.f. could upregulate NLRP3 expression in EGCs and promote an inflammatory response. B.b. had a dual regulatory role in EGC NLRP6 expression, while B.f. inhibited NLRP6 protein expression. Moreover, B.b. could decrease the expression of IL-18, IL-1β, and caspase-1 in EGCs in order to inhibit the inflammatory response. Contrary to this, B.f. could upregulate IL-18, IL-1β, and caspase-1 expression in EGCs in order to promote the inflammatory response. B.b. and B.f. can influence the expression of NGF, NT-3, NLRP3, NLRP6, IL-18, IL-1β, and caspase-1 in EGCs in order to inhibit or promote intestinal inflammation.

Entities:  

Keywords:  Bacteroides fragilis; Bifidobacterium bifidum; enteric glial cells

Mesh:

Substances:

Year:  2020        PMID: 32638263     DOI: 10.1007/s10753-020-01284-z

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  39 in total

Review 1.  Inflammasomes and intestinal homeostasis: regulating and connecting infection, inflammation and the microbiota.

Authors:  Nicola Gagliani; Noah W Palm; Marcel R de Zoete; Richard A Flavell
Journal:  Int Immunol       Date:  2014-06-19       Impact factor: 4.823

Review 2.  Post-infectious irritable bowel syndrome: the past, the present and the future.

Authors:  Uday C Ghoshal; Prabhat Ranjan
Journal:  J Gastroenterol Hepatol       Date:  2011-04       Impact factor: 4.029

3.  Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome.

Authors:  J Serra; F Azpiroz; J R Malagelada
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

Review 4.  Infection, inflammation, and the irritable bowel syndrome.

Authors:  R Spiller; K Garsed
Journal:  Dig Liver Dis       Date:  2009-08-28       Impact factor: 4.088

Review 5.  A role for inflammation in irritable bowel syndrome?

Authors:  G Barbara; R De Giorgio; V Stanghellini; C Cremon; R Corinaldesi
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

6.  Health-related quality of life in patients attending a gastroenterology outpatient clinic: functional disorders versus organic diseases.

Authors:  Magnus Simrén; Jan Svedlund; Iris Posserud; Einar S Björnsson; Hasse Abrahamsson
Journal:  Clin Gastroenterol Hepatol       Date:  2006-02       Impact factor: 11.382

7.  Comorbidity in irritable bowel syndrome.

Authors:  William E Whitehead; Olafur S Palsson; Rona R Levy; Andrew D Feld; Marsha Turner; Michael Von Korff
Journal:  Am J Gastroenterol       Date:  2007-09-26       Impact factor: 10.864

8.  Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome.

Authors:  Ji Chen; Yangde Zhang; Zhansheng Deng
Journal:  BMC Gastroenterol       Date:  2012-07-20       Impact factor: 3.067

9.  Intestinal microbiota in functional bowel disorders: a Rome foundation report.

Authors:  Magnus Simrén; Giovanni Barbara; Harry J Flint; Brennan M R Spiegel; Robin C Spiller; Stephen Vanner; Elena F Verdu; Peter J Whorwell; Erwin G Zoetendal
Journal:  Gut       Date:  2012-06-22       Impact factor: 23.059

10.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

View more
  5 in total

1.  Genome-wide siRNA screening reveals several host receptors for the binding of human gut commensal Bifidobacterium bifidum.

Authors:  Veera Kainulainen; Carina von Schantz-Fant; Ruusu-Maria Kovanen; Swapnil Potdar; Karoliina Laamanen; Jani Saarela; Reetta Satokari
Journal:  NPJ Biofilms Microbiomes       Date:  2022-06-29       Impact factor: 8.462

2.  Role of GDNF, GFRα1 and GFAP in a Bifidobacterium-Intervention Induced Mouse Model of Intestinal Neuronal Dysplasia.

Authors:  Wei Liu; Tingting Zhou; Jinqiu Tian; Xiaofang Yu; Chuantao Ren; Zengcai Cao; Peimin Hou; Qiangye Zhang; Aiwu Li
Journal:  Front Pediatr       Date:  2022-01-14       Impact factor: 3.418

3.  Ileal Microbiota Alters the Immunity Statues to Affect Body Weight in Muscovy Ducks.

Authors:  Zixian Fu; Hua Yang; Yingping Xiao; Xiaoli Wang; Caimei Yang; Lizhi Lu; Wen Wang; Wentao Lyu
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

4.  Association Between Gut Microbiota and Autoimmune Thyroid Disease: A Systematic Review and Meta-Analysis.

Authors:  Boshen Gong; Chuyuan Wang; Fanrui Meng; Haoyu Wang; Bo Song; Yang Yang; Zhongyan Shan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-17       Impact factor: 5.555

Review 5.  Enteric Glial Cells in Immunological Disorders of the Gut.

Authors:  Chang Liu; Jing Yang
Journal:  Front Cell Neurosci       Date:  2022-04-28       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.